Evidence map›Paper›PMID 31905705›Full record

ArticleInternational journal of molecular sciences2019

Food-Derived Collagen Peptides, Prolyl-Hydroxyproline (Pro-Hyp), and Hydroxyprolyl-Glycine (Hyp-Gly) Enhance Growth of Primary Cultured Mouse Skin Fibroblast Using Fetal Bovine Serum Free from Hydroxyprolyl Peptide.

Tomoko T Asai, Fumi Oikawa, Kazunobu Yoshikawa, Naoki Inoue, Kenji Sato

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. From Reshaped Metabolome to Repaired Skin: FermentedAntioxidants (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. The Efficacy and Safety of CollaSel ProJournal of clinical medicine · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. The effects of aqueous extract ofFrontiers in pharmacology · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Peptides for Health Benefits 2019.International journal of molecular sciences · 2020
    Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Tomoko T AsaiDivision of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Kyoto 606 8502, Japan.
Fumi OikawaDivision of Applied Life Sciences, Graduate School of Life and Environment Sciences, Kyoto Prefectural University, Kyoto 606 8522, Japan.
Kazunobu YoshikawaDivision of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Kyoto 606 8502, Japan.
Naoki InouePeptide Division, Nitta Gelatin Inc., 2-22 Futamata, Yao, Osaka 581 0024, Japan.
Kenji SatoDivision of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Kyoto 606 8502, Japan.
Kyoto University · JPKyoto Prefectural University · JPPeptide Institute (Japan) · JP

Funding

Nitta Gelatin Inc. 150151000045
6 · The paper itself

Abstract

Prolyl-hydroxyproline (Pro-Hyp) and hydroxyprolyl-glycine (Hyp-Gly) appear in human blood after ingestion of collagen hydrolysate and trigger growth of fibroblasts attached on collagen gel, which has been associated with beneficial effects upon ingestion of collagen hydrolysate, such as improvement of skin and joint conditions. In the present study, inconsistent results were obtained by using different lots of fetal bovine serum (FBS). Fibroblasts proliferated in collagen gel without adding Pro-Hyp and Hyp-Gly and did not respond to addition of Pro-Hyp and Hyp-Gly, which raises doubts about conclusions from prior research. Unexpectedly high levels of hydroxyprolyl peptides, including Pro-Hyp, however, were present in the FBS (approximately 100 µM), and also in other commercially available forms of FBS (70-80 µM). After removal of low molecular weight (LMW, < 6000 Da) compounds from the FBS by size exclusion chromatography, Pro-Hyp and Hyp-Gly again triggered growth of fibroblasts attached on collagen and increased the number of fibroblasts migrated from mouse skin. These results indicate the presence of bioactive hydroxyprolyl peptides in commercially available FBS, which can mask effects of Pro-Hyp and Hyp-Gly supplementation; our work confirms that Pro-Hyp and Hyp-Gly do play crucial roles in proliferation of fibroblasts.

Indexed as

Cell ProliferationAnimalsCattleCells, CulturedCollagenDipeptidesFibroblastsMaleMiceMice, Inbred BALB CSerumSkinCollagenDipeptideshydroxyprolyl-glycineprolyl-4-hydroxyprolinecollagen peptidefetal bovine serum (FBS)fibroblastshydroxyprolyl-glycine (Hyp-Gly)prolyl-hydroxyproline (Pro-Hyp)

Identifiers

PMID31905705
PMCPMC6982277
OpenAlexW2998651767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.